Drug survival of anakinra and canakinumab in monogenic autoinflammatory diseases: Observational study from the International AIDA Registry

Citation:
Sota, J., D. Rigante, R. Cimaz, M. Cattalini, M. Frassi, R. Manna, L. L. Sicignano, E. Verrecchia, E. Aragona, M. C. Maggio, et al., "Drug survival of anakinra and canakinumab in monogenic autoinflammatory diseases: Observational study from the International AIDA Registry", Rheumatology (United Kingdom), vol. 60, issue 12: Oxford University Press, pp. 5705 - 5712, 2021.

Abstract:

n/a

Notes:

Cited By :3Export Date: 26 July 2022CODEN: RUMAFCorrespondence Address: Cantarini, L.; Research Centre of Systemic Autoinflammatory Diseases, viale Bracci 16, Italy; email: cantariniluca@hotmail.com

Related External Link

Tourism